People with psoriasis will have new treatment option instead of Humira – Chicago Sun-Times

People with psoriasis will have a new treatment option for the itchy, sometimes painful condition, after the federal Food and Drug Administration approved a new psoriasis drug.

The FDA approved Tremfya for treatment of moderate to severe plaque psoriasis.

Johnson & Johnson said that, in one patient study, about seven in 10 patients getting Tremfya had clear or nearly clear skin after 24 weeks of treatment.

That compares with about four in 10 patients receiving rival AbbVies Humira, which treats several immune disorders and is the worlds top-selling drug. AbbVie is based in North Chicago.

The drug, which has the chemical name guselkumab, will cost $9,684 per dose, or about $58,100 per year, without insurance. Thats comparable to Humira, which costs about $59,200 a year.

Tremfya, which is injected every eight weeks, can cause infections and other serious side effects. Because it suppresses part of the immune system, it can increase the risk of developing tuberculosis and some types of cancer.

More than 7.5 million Americans are estimated to have psoriasis, a chronic inflammatory condition in which overproduction of skin cells causes raised red lesions called plaques, along with frequent pain, itching and burning sensations. Tremfya was able to both clear up lesions and help relieve those symptoms.

Johnson & Johnson, based in New Brunswick, New Jersey, sells other immune disorder treatment such as Remicade and Stelara for conditions including Crohns disease, ulcerative colitis and rheumatoid arthritis.

Originally posted here:

People with psoriasis will have new treatment option instead of Humira - Chicago Sun-Times

Psoriasis- What You Need To Know – Reports Healthcare

Psoriasis is unpredictable, infuriating and among the most perplex skin disorders. It is a condition in which your skin cells start multiplying at a rate ten times faster than the normal one. When the underlying cells skin cells move towards the surface of the skin and die, they cause red plaques all over the skin due to their sheer volume.

About 7.5 million people are said to get affected by psoriasis in America. Not only does this disease harm the skin, it can also result in several other complications such as psoriatic arthritis, inflammatory bowel disease, diabetes type 2 and cardiovascular problems. Therefore, it is important to know the manifestations and diagnosis of psoriasis in order to deal with this irritating skin disease as fast as possible.

What Happens In Psoriasis

As mentioned before, psoriasis occurs when the skin production process is sped up. In a typical individual, it takes a month for the skin cells to grow in the skin, rise to the surface and fall off eventually.

In people with psoriasis, this process is sped up to a few days only. This means that the skin cells are not given enough time to fall off in a normal way. An overproduction of these cells occurs which causes the development of plaques in them.

Scales are usually seen in the body of such patients. The most common areas where they can be seen are elbows, joints and knees. Scales can also grow on other parts of the body such as neck, hands, scalp, feet and face.

Less commonly, psoriasis can also be seen attacking the mouth, nails and the area surrounding the genitals.

Causes Of Psoriasis

Scientists have categorized the reasons for psoriasis according to the two key factors- the immune system and the genetic makeup.

Immune System

Psoriasis is an autoimmune disease in which the body starts attacking its own cells. In this disease, the white blood cells or the T cells present in your blood start harming the skin cells.

In a normal individual, white blood cells are designated to destroy all the bacteria that make their way into your body and to fight them before they start spreading infection. These cells mistakenly start targeting the normal skin cells leading to overdriving of their production. New skin cells are quickly generated and start piling up on the surface of the skin.

Plaques are formed that are normally surrounded by inflammation in this case.

Genetic Makeup

The genetic makeup of a certain individual also makes him more vulnerable to developing psoriasis. If any one of your immediate family members is suffering from a skin disease, you are more prone to acquire psoriasis as well. However, only 2 to 3 percent of the people suffer from psoriasis due to genetic setup is quite less.

Is Psoriasis Transmissible?

Psoriasis is not generally contagious and the patient is unable to transmit this disease to the people surrounding him. Even if you come in direct contact with a psoriatic lesion, you will not acquire it.

Signs And Symptoms Of Psoriasis

The symptoms of this skin disorder can vary from person to person. However, the most commonly seen manifestations are mentioned below:

Treatment Options For Psoriasis

In general, psoriasis is untreatable. Medications can be prescribed to decrease the scales, slow down the growth cycle of skin cells and to reduce inflammation.

Several ointments and creams are given to be applied on the infected area. These topical treatments may include the use of topical retinoids, topical corticosteroids, salicylic acid and vitamin D analogues.

Systemic treatments are given to people who have moderate to severe form of psoriasis and do not respond to the topical treatment. The commonly prescribed medicine groups are biologics, cyclosporine and retinoids.

This treatment regimen involves the use of ultraviolet light or even the natural light to stop overactive T cells in the body. Symptoms of psoriasis are said to be reduced using UVA and UVB light.

More:

Psoriasis- What You Need To Know - Reports Healthcare

FDA clears Philips’ light therapy wearable for mild psoriasis … – FierceBiotech

Philips scored FDA clearance for its wearable light therapy device for the treatment of psoriasis. The rechargeable device delivers blue LED light to the skin in a drug-free approach that controls the symptoms of mild psoriasis.

Characterized by patches of thick, red inflamed skin covered with scales, psoriasis occurs when skin cells quickly rise to the surface, where they build up before they mature. The chronic disease affects more than 6.7 million adults in the U.S., according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Philips launched the first-generation BlueControl system in Germany, the Netherlands and the U.K. in October 2014. The following year, the company earned a CE mark for the devices follow-up, which was introduced in additional markets, including Denmark, Finland, Sweden and Poland. The FDA has cleared it as a prescription device for home use.

RELATED: MetrioPharm advances psoriasis drug after phase 2 readout

A patient secures the BlueControl device on the affected body part using adjustable straps. The blue light triggers natural processes in the skin that ease the symptoms of psoriasis, which include redness and scaling. Specifically, it slows down the accelerated production of skin cells that results in plaques.

In addition to light therapy, psoriasis is commonly treated with pharmaceuticals. Topical treatments such as ointments or creams containing corticosteroids work well for some patients, but some patients with severe psoriasis may need medications that are taken orally or by injection. These include immune suppressants and drugs that interfere with specific immune system functions that cause the overproduction of skin cells.

RELATED: J&J's Tremfya gets its go-ahead to fight Novartis, Lilly in psoriasis. Can it stand out?

Patients who take immune-suppressing drugs are at higher risk of infection. Using light therapy alone, or in combination with medicationwhich allows a lower dose of eachis an attractive way to reduce thisrisk.

Now, Philips plans to engage with dermatologists and patient support groups in the U.S., with eyes on commercial launch early next year.

See the original post here:

FDA clears Philips' light therapy wearable for mild psoriasis ... - FierceBiotech

FDA OKs new Johnson & Johnson treatment for psoriasis – ABC News

U.S. regulators approved a new psoriasis drug from Johnson & Johnson Thursday, giving people with the itchy and painful condition another treatment option.

Johnson & Johnson said that in one patient study, about seven in 10 patients getting the drug, Tremfya, had clear or nearly clear skin after 24 weeks of treatment. That compares with about four in 10 patients receiving rival AbbVie's Humira, which treats several immune disorders and is the world's top selling drug.

Tremfya, which is injected every eight weeks, can cause infections and other serious side effects. Because it suppresses part of the immune system, it can increase the risk of developing tuberculosis and some types of cancer.

The drug, which has the chemical name guselkumab, will cost $9,684 per dose, or about $58,100 per year, without insurance. That's comparable to Humira, which costs about $59,200 a year.

More than 7.5 million Americans are estimated to have psoriasis, a chronic inflammatory condition in which overproduction of skin cells causes raised red lesions called plaques, along with frequent pain, itching and burning sensations. Tremfya was able to both clear up lesions and help relieve those symptoms.

Johnson & Johnson, based in New Brunswick, New Jersey, sells other immune disorder treatment such as Remicade and Stelara for conditions including Crohn's disease, ulcerative colitis and rheumatoid arthritis.

Follow Linda A. Johnson at https://twitter.com/LindaJonPharma .

See the original post here:

FDA OKs new Johnson & Johnson treatment for psoriasis - ABC News

FDA Clears At-Home Light Therapy Device for Psoriasis – Monthly Prescribing Reference (registration)

July 13, 2017

The device straps to affected psoriasis areas (ie, arms, legs, elbows, knees) and emits a UV-free blue LED light

The Philips BlueControl wearable light therapy device has been approved by the Food and Drug Administration (FDA) to treat mild psoriasis.

The device straps to affected psoriasis areas (ie, arms, legs, elbows, knees) and emits a UV-free blue LED light. It is designated a Class II prescription medical device.

A clinical trial (Pfaff S et al. 2015) of 47 individuals with mild psoriasis found significant improvement in change from baseline of Local Psoriasis Severity Index in patients receiving UV-free blue light home treatment.

The Philips BlueControl has been available in Europe since 2015. We are pleased that we can now start marketing this innovative home treatment solution for psoriasis to dermatologists in the U.S. said David Aubert, General Manager of Philips' Light & Health business.

The company indicated that they will start to engage with dermatologists and patient support groups for a planned commercial U.S. launch in early 2018.

For more information visit Philips.com.

See original here:

FDA Clears At-Home Light Therapy Device for Psoriasis - Monthly Prescribing Reference (registration)

Including Kim Kardashian & Maybe You:Treatment Options – Hollywood Life

Believe it or not, the skin disease, psoriasis, affects 7.5M people including Kim Kardashian & maybe you! Dont fret, because we have expert doctor tips on fast treatment options you can try!

The skin disease, psoriasis, affects millions of people, including Kim Kardashian, and you may be one of the 7.5 million people that suffers from it. While it sounds like a seriously scary disease, dont be nervous, because there are many different treatment options you can try to control it and thankfully, it is not contagious. We spoke exclusively to Jennifer C. Cather, MD, with the Modern Dermatology-Aesthetics Center in Dallas, Texas, on what exactly psoriasis is and how you can treat it fast.

Psoriasis affects approximately 7.5 million people in the U.S. alone. It affects both men and women equally and occurs in all racial groups at varying rates. While the disease can begin at any age, it most often develops between ages 20 to 30 and 50 to 60. Its also important to note that up to 30% of people with psoriasis eventually develop psoriatic arthritis, which involves joint inflammation.

Psoriasis is a common, chronic skin condition causing increased skin cell growth that may appear on the skin as raised, sometimes red patches covered with a silvery buildup of dead skin cells. What people may not know is that its an inflammatory, systemic disease meaning that it can affect the entire body. Psoriasis is also not contagious.

While both eczema and psoriasis are inflammatory skin diseases that involve skin lesions, which may look similar, the distribution geographically is usually different. Eczema is more on the allergy spectrum so patients oftentimes experience other symptoms such as hay fever, asthma or hives. Eczema does not have associated arthritis tied to it, but for psoriasis, up to 30% of people with the condition may eventually develop psoriatic arthritis, which involves joint inflammation.

There are various options for the treatment of moderate to severe plaque psoriasis. These include over-the-counter lotions and prescription medications such as creams; oral medicines; phototherapy with ultraviolet light; and biologic agents that are given by injection. There are several ways to help manage psoriasis, including treatment as well as lifestyle changes, so people should work closely with their dermatologist to discuss what their options and create a treatment plan that works for them.

See the rest here:

Including Kim Kardashian & Maybe You:Treatment Options - Hollywood Life

What is up with Kim Kardashian West’s leg? – Body and Soul

What you need to know about the common condition, according to a dermatologist.

Psoriasis is an immune-mediated inflammatory disease that affects millions of people, Kim Kardashian West being just one of them.

This week the beauty magnate stepped out in Manhattan, and her shin had flared up in a manner typical to the non-contagious condition, as anyone who also suffers would know. (The itchiness? Its real.)

Photo: Getty ImagesSource:BodyAndSoul

But, while psoriasis affects 1.4 million Australians (or, around 2-4 per cent of the population, according to dermatologist Dr Natasha Cook of Darlinghurst Dermatology in Sydney) there is still a great deal of misinformation and misunderstanding among people who dont suffer from it - and even some who do.

First up, according to Dr Cook, psoriasis can cause red, scaly patches on your skin, irregular texture of your nails, and dandruff, and affects both sexes. If you think for the first time in your life you might be dealing with this, book an appointment with your GP who will be able to advise a correct treatment plan, as psoriasis can occur at any life stage to anyone (though it does tend to peak in early adulthood).

Your scalp, knees, elbows, hands, and feet are the most typically affected areas, though as Dr Cook explains it can occur anywhere on your body and as new cells mix with old cells, an accumulation on your skin occurs, which leads to raised red lesions called plaques on the body. Ouch.

According to Dr Cook, the condition has many triggers (genetic, for starters, as a third of people who are diagnosed have a family member who suffers, too) and a host of environmental and lifestyle factors can activate it, too.

Sore throats from a streptococcal infection can unmask a type of psoriasis known as guttate psoriasis, according to Dr Cook, as can trauma to the skin like bad sunburn, as can lifestyle factors smoking, excessive drinking, and being overweight can cause flare-ups, too... and another huge factor is stress, though it can still occur without these triggers at play.

According to Dr Cook, the cold weather can bring on psoriasis more than the heat (which might explain a few things, come to think of it) as winter dries out the skin more. Plus, the sun helps peoples psoriasis as it suppresses the immune system, and given this is an overactive immune disorder, it helps many cases.

And, while it cant be solved with a contour kit (sadly) there are certainly things you can do to keep the symptoms under control, says Dr Cook, like eating well, moisturising, de-stressing with meditation, yoga and quitting smoking, for starters. (All of which is sound advice, we think youll agree.)

Though, as every case (and every body) is different, its best to consult a healthcare professional for the right treatment for you.

Chloe went 2 nights with only 4 hours sleep to see what effect sleep deprivation had on her body and mind.

More:

What is up with Kim Kardashian West's leg? - Body and Soul

NICE recommends drugs for plaque psoriasis in young people – The Pharma Letter (registration)

The National Institute for Health and Care Excellence (NICE) today published guidance recommending approval

To continue reading this article and to access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space you need to be logged into the site and have an active subscription or trial subscription. Please loginorsubscribe in order to continue reading. Claim a week's trial subscriptionby signing up for free today and receive our daily pharma and biotech news bulletin free of charge, forever.

AbbVieBiotechnologyDermatologicalsEnbrelHumiraJanssenPfizerPricingRegulationStelaraUK

Access The Pharma Letter's latest news free for 7 days

PLUS... you can receive the Pharma Letter headlines and news roundup email free forever

Click here to take a free trial

Unlimited access to The Pharma Letter site for a whole year Only 77 per month or 820 per year

Click here to subscribe

Link:

NICE recommends drugs for plaque psoriasis in young people - The Pharma Letter (registration)

The Psoriasis Myth – Medical News Bulletin

Myth: Psoriasis is a disease that will impact someone for the entire lifetime, there is no cure.

Truth: This is false. Almost psoriasis is a very persistent disease, there are number of treatments that can be used to help combat this ailment. Psoriasis is an inflammatory skin disease in which the bodys immune cells start to attack itself. Psoriasis affects approximately 2% of all adults and is often associated with a poor quality of life and other diseases such as obesity and diabetes hypertension and metabolic syndrome. In this disease, an immune cell called interleukin-23 is hypothesized to play an important role in the bodys inappropriate inflammatory state. This Al is believed to be responsible for inducing and maintaining inflammatory cells. Currently, there are a number of available therapies that can be used to help treat psoriasis. Some of these treatments include antibodies whose purpose is to attack immune cells responsible for the inflammatory response in the body. One example is Ustekinumab, which targets a subunit in interleukin-23. Previous research has shown that this drug is safe, well-tolerated, and effective in treating psoriasis patients.

Recently, a clinical trial compared the efficacy onset, and duration of clinical response between Ustekinumab and another antibody drug, risankizumab. In this study, patients were administered one of the two antibodies and were analyzed for their responses. Although both drugs prove to be effective against arises in more than half of the patients, it was found that Usenkinumab was more effective. As well, it was found that patients who were administered Usenkinumab had both faster and longer benefits in response to this drug, in comparison to riskankizumab. Read more about the effectiveness of different antibody treatments in psoriasis here.

Go here to see the original:

The Psoriasis Myth - Medical News Bulletin

Paolo Bediones admits suffering from psoriasis – ABS-CBN News

Paolo Bediones. Facebook.com/paolo.bediones

MANILA - Host Paolo Bediones surprised his social media followers when he admitted that he is suffering from psoriasis.

In a Facebook post on July 5, Bediones said he has been keeping his condition a secret "for more than half my life."

He turned 43 last March.

"I HAVE PSORIASIS. Don't worry, it's a non-communicable skin disorder. It is NOT CONTAGIOUS. It's a painful, chronic disease characterized by incessant itching and scratching. Occasional bleeding and scabbing. Reddening of the skin and flaking. It's not pretty for sure, but I have been hiding it well," he wrote in the post, which has been shared more than 1,000 times as of writing.

Bediones went on to shed light on the plight of his fellow psoriasis patients in the country.

"More than 2 million of my KABALAT in the country suffer the daily plight of flare ups that are mild to severe, that happen during bouts of stress and heat, and sometimes it's caused by the food we eat. Some have even perished from the ordeal.

"Every day we have to mentally prepare ourselves before we go out into the world. Each one of us insecure, knowing someone will notice the discolored patch of skin or the white flakes. Knowing someone would like to ask about it, but feel uncomfortable doing so," he said.

The TV anchor then asked the public to show their support for psoriasis patients and encourage them to seek treatment.

"If you, a family member, or a friend share these symptoms, look up Psor Phil and please see a specialist and learn about the various forms of treatment that exists. If you know anyone with psoriasis, hug them. If you see me on the street, hug me," he ended.

Other celebrities who have opened up about suffering from psoriasis include reality TV star Kim Kardashian and singer Britney Spears.

Continue reading here:

Paolo Bediones admits suffering from psoriasis - ABS-CBN News

"Scandal" Star Opens Up About Her Experience with Psoriasis – KDRV


KDRV
"Scandal" Star Opens Up About Her Experience with Psoriasis
KDRV
She says right around the time she started the big role, she was diagnosed with psoriasis. The disease causes red, scaly patches on the skin that itch and burn. Not only is it painful, some say it can be embarrassing. Katie Lowes says she dealt with ...

Go here to read the rest:

"Scandal" Star Opens Up About Her Experience with Psoriasis - KDRV

Psoriasis causes and known triggers | National Psoriasis …

Scientists believe that at least 10 percent of people inherit one or more of the genes that could eventually lead to psoriasis. However, only 2 percent to 3 percent of the population develops the disease. Researchers believe that for a person to develop psoriasis, that person must have a combination of the genes that cause psoriasis and be exposed to specific external factors known as triggers.

Genes control everything about a person, from height to eye color. When genes are working normally, the body and its cells function normally. When a misstep occurs in the way a gene works, a genetic disease such as psoriasis may result.

Research into the genetics of psoriasis didnt begin until the early 1970s. Recently, it has exploded in scope, thanks to improvements in medical and genetic technology, and increased funding.

In 2006, the Foundation began collecting DNA samples for the National Psoriasis Victor Henschel BioBank. The BioBank is slated to be the worlds largest collection of psoriasis-related DNA in the world available to qualified researchers. The first BioBank DNA samples were released to researchers in 2010.

Scientists have now identified about 25 genetic variants that make a person more likely to develop psoriatic disease. At the University of Michigan, Dr. J.T. Elder and his team of researchers have identified several areas on the human genome where more than one gene may be involved in psoriasis and psoriatic arthritis.

At the University of California-San Francisco, Dr. Wilson Liao is using new genetic sequencing technology to find rare "trigger genes" that may be the leading causes of psoriasis in certain individuals.

Working with DNA samples from a large family that includes many people with psoriasis, Anne Bowcock, Ph.D., a professor of genetics at Washington University School of Medicine in St. Louis, has identified a gene mutation known as CARD14 that when triggered leads to plaque psoriasis.

At the University of Utah, Drs. Gerald Krueger and Kristina Callis Duffin have carefully catalogued the psoriasis of more than 1,200 patients. By comparing the genes of each individual to the way psoriasis shows up on his or her body, the team hopes to understand which genes are involved in specific types of disease.

Using a NPF Discovery grant, British researcher Francesca Capon found that a mutation to the gene called IL36RN might be involved in the three forms of pustular psoriasis.

Psoriasis triggers are not universal. What may cause one person's psoriasis to become active, may not affect another. Established psoriasis triggers include:

Stress can cause psoriasis to flare for the first time or aggravate existing psoriasis. Relaxation and stress reduction may help prevent stress from impacting psoriasis.

Psoriasis can appear in areas of the skin that have been injured or traumatized. This is called the Koebner [KEB-ner] phenomenon. Vaccinations, sunburns and scratches can all trigger a Koebner response. The Koebner phenomenon can be treated if it is caught early enough.

Certain medications are associated with triggering psoriasis, including:

Anything that can affect the immune system can affect psoriasis. In particular, streptococcus infection (strep throat) is associated with guttate psoriasis. Strep throat often is triggers the first onset of guttate psoriasis in children. You may experience a flare-up following an earache, bronchitis, tonsillitis or a respiratory infection, too.

It's not unusual for someone to have an active psoriasis flare with no strep throat symptoms. Talk with your doctor about getting a strep throat test if your psoriasis flares.

Although scientifically unproven, some people with psoriasis suspect that allergies, diet and weather trigger their psoriasis.

NPF's Patient Navigation Center is the world's first, personalized support center for psoriatic disease. Our Patient Navigatorscan answer your questions about flare-ups,help you better manage your symptoms and support your journey to a healthy life with psoriasis.

For free and confidential assistance, contact our Patient Navigators

Originally posted here:

Psoriasis causes and known triggers | National Psoriasis ...

10 Ways to Treat Psoriasis at Home – Healthline

Treating psoriasis

Psoriasis is a recurring autoimmune disorder characterized by red, flaky patches on the skin. Even though it affects your skin, psoriasis actually begins deep inside, in your immune system. It comes from your T cells, a type of white blood cell. T cells are designed to protect the body from infection and disease. When these cells mistakenly become active and set off other immune responses, it can lead to psoriasis symptoms.

Even though there is no cure, many treatments exist to ease the symptoms of psoriasis. Here are 10 ways to manage mild symptoms from the comfort of your home.

Dietary supplements may help ease psoriasis symptoms from the inside. Fish oil, vitamin D, milk thistle, aloe vera, Oregon grape, and evening primrose oil have been reported to help ease mild symptoms of psoriasis, according to the National Psoriasis Foundation. It's important to only take supplements that dont interfere with other pre-existing conditions you may have.

Use a humidifier to keep the air in your home or office moist. It can prevent dry skin before it starts. Sensitive skin moisturizers are also great at keeping your skin supple and from forming plaques.

Most soaps and perfumes have dyes and other chemicals in them that may irritate your skin. Sure, they can make you smell great but they also can inflame psoriasis. Avoid such products when you can, or choose those with sensitive skin labels.

Diet may play a role in managing psoriasis. Eliminating red meat and fatty snacks may help reduce flare-ups that can be triggered by such foods. Cold water fish, seeds, nuts, and omega-3 fatty acids are known for their ability to reduce inflammation. This can be helpful for managing psoriasis symptoms. Olive oil may also have soothing benefits when applied topically to the skin. Try massaging a few tablespoons on your scalp to help loosen troublesome plaques during your next shower.

Hot water may be an irritant for your skin. However, a lukewarm bath with Epsom salt, mineral oil, milk, or olive oil can soothe the itching and infiltrate scales and plaques. Moisturize immediately after your bath for double benefits.

During light therapy, a doctor will shine ultraviolet light on the skin. This type of therapy often requires consistent and frequent sessions. It should be noted that tanning beds are not a means of achieving light therapy. Too much sunlight can actually worsen psoriasis. This procedure should always be done under the supervision of your doctor.

Any chronic condition like psoriasis can be a source of stress. This can often turn into a vicious cycle when stress itself can worsen psoriasis symptoms. In addition to reducing stress whenever possible, consider incorporating stress-reducing practices such as yoga and meditation.

Alcohol is a trigger for many people who have psoriasis. A study from Brigham and Womens Hospital and Harvard Medical School found an increased risk of psoriasis among women who drank nonlight beer. Those who drank at least five nonlight beers per week were nearly twice as likely to develop psoriasis, when compared to women who didnt drink.

Herbs are commonly used to treat many conditions. Turmeric has been found to help minimize psoriasis flare-ups. It can be taken in pill or supplement form or sprinkled on your food. Talk to your doctor about the potential benefits for you. The FDA-approved dosage of turmeric is 1.5 to 3.0 grams per day.

Avoid tobacco. Smoking may increase your risk of psoriasis. If you already have psoriasis, it can also make your symptoms more severe.

There isnt a single answer for keeping the symptoms of psoriasis at bay. What works for one person may not work for another. Some treatment options may have negative side effects for pre-existing conditions other than psoriasis. It is important to remember that while these home remedies for psoriasis my help with mild cases, prescription therapy is required for refractory or more severe cases. Talk to your doctor before seeking treatment on your own.

Were unable to offer personal health advice, but weve partnered with trusted telehealth provider Amwell, who can connect you with a doctor. Try Amwell telehealth for $1 by using the code HEALTHLINE.

If you're facing a medical emergency, call your local emergency services immediately, or visit the nearest emergency room or urgent care center.

We are unable to collect your feedback at this time. However, your feedback is important to us. Please try again later.

Let's be friends join our Facebook community.

We'll share your response with our medical review team, who will update any incorrect information in the article.

We're sorry you're unsatisfied with what you've read. Your suggestions will help us improve this article.

Continue reading here:

10 Ways to Treat Psoriasis at Home - Healthline

CMO Samsung BioLogics Inks Deal to Manufacture Plaque Psoriasis Inhibitor – Pharmaceutical Processing

Sun Pharma and Samsung BioLogics announce strategic manufacturing tie-up for tildrakizumab.

Sun Pharmaand Samsung BioLogics announced a strategic long-term manufacturing agreement for tildrakizumab. The agreement was entered into by Sun Pharma's wholly owned subsidiary and Samsung BioLogics. According to the agreement, Sun Pharma has appointed Samsung BioLogics to manufacture tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis.

Filings for the novel investigational biologic was accepted for review by the U.S. Food and Drug Administration (FDA) in May and the European Medicines Agency (EMA) in March. The agreement was signed at Samsung BioLogics' headquarters in Incheon,South Korea. The approximate value of the contract will be $55.5 million. Other financial details of the agreement were confidential.

"Samsung BioLogics is a globally renowned CMO. Through this partnership we will leverage Samsung's manufacturing knowledge and world class quality systems to provide high quality products for the tildrakizumab pipeline,"Kirti Ganorkar, global headportfolio management and business development atSun Pharma, said.

Tildrakizumab is an investigational humanized, anti-IL-23p19 monoclonal antibody designed to selectively block the cytokine IL-23. With this precise targeting, tildrakizumab has the potential to help control the pathogenic cells responsible for the inflammatory process of psoriasis with limited impact on the rest of the immune system.

Phase-3 tildrakizumab data provide further evidence for the role of the IL-23 pathway in helping to control the inflammatory process of psoriasis. The regulatory filings associated with tildrakizumab have been accepted for review by the FDA and EMA.

A Sun Pharmaceutical Industries Ltd. wholly owned subsidiary received worldwide rights to tildrakizumab from Merck, known as MSD outsidethe United StatesandCanada, in 2014. Funded by a Sun Pharma subsidiary, Merck is responsible for the completion of Phase-3 trials in patients with mild-to-moderate plaque psoriasis and, as appropriate, submission of a Biologics License Application to the United States Food and Drug Administration (FDA). Merck is also responsible for manufacturing finished goods to support Sun Pharma's initial product launch.

Post-approval in the U.S., Sun Pharma will be responsible for all other regulatory activities, including subsequent submissions, pharmacovigilance, post approval studies, manufacturing and commercialization of the approved product. Sun Pharma will also be responsible for all regulatory, pharmacovigilance, post approval studies, manufacturing and commercialization of approved products for all non-U.S. markets. Merck is eligible to receive milestone payments and royalties on sales of tildrakizumab.

(Source: PR Newswire)

Read more:

CMO Samsung BioLogics Inks Deal to Manufacture Plaque Psoriasis Inhibitor - Pharmaceutical Processing

Novartis’ psoriasis drug gets label boost – pharmaphorum

Novartis could gain further traction in the psoriasis drug market after European regulators granted a label update showing the firms Cosentyx clears skin better than Johnson & Johnsons rival, Stelara.

Europes CHMP scientific committee approved the label update for Cosentyx (secukinumab), the first interleukin-17A approved to treat psoriasis.

Sales of Cosentyx, which is injected every four weeks, are mounting and the drug looks set to achieve blockbuster status, with sales expected to peak at around $4 billion.

But the market is highly competitive, with a range of disease modifying drugs available and Stelara establishing itself as a mainstay treatment.

Results of the CLEAR study showing Cosentyx is better at clearing skin than Stelara first emerged at the European Academy of Dermatology and Venerology (EADV) conference in October.

Data presented at the congress in Vienna, showed Cosentyx is significantly superior to J&Js Stelara (ustekinumab)in delivering long-lasting skin clearance in psoriasis over 52 weeks.

Further data published at the congress also showed long-lasting clear or almost clear skin in the vast majority of patients, with a favourable safety profile over four years.

Almost all response rates are maintained from year one to year four, according to data.

The four-year data was based on assessments using the Psoriasis Area Severity Index (PASI) 90 (almost clear skin), and PASI 100 (clear skin).

The label update also includes data on the treatment of scalp psoriasis, a particularly difficult form of the disease to treat as activity is often maintained through hair care, scratching and shampooing.

Vas Narasimhan, Novartis chief medical officer, said: We are continually investigating new areas for Cosentyx to significantly enhance patients quality of life, such as scalp psoriasis.

See original here:

Novartis' psoriasis drug gets label boost - pharmaphorum

Sun shines on CMO Samsung Biologics to make its psoriasis mAb candidate – BioPharma-Reporter.com

Samsung Biologics will make Sun Pharmas psoriasis monoclonal antibody candidate Tildrakizumab in a deal worth $55.5m.

Indias Sun Pharmaceutical Industries acquired the rights to the anti-IL-23p19 candidate from Merck & Co. in 2014 and today announced it has selected Korean contract manufacturing organisation (CMO) Samsung Biologics to make the monoclonal antibody.

Tildrakizumab which has been accepted for review by both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) in March and May, respectively is being developed to control the pathogenic cells responsible for the inflammatory process of psoriasis by selectively blocking the cytokine IL-23.

Production will take place at Samsung Biologics mammalian manufacturing site in Incheon, South Korea which currently houses 180,000L of stainless steel capacity across two plants, with a third plant set to double capacity expected to come online next year.

The deal is worth around $55.5m (49m), though when contacted neither Sun Pharma nor Samsung Biologics divulged any further details.

From conception to one-stop-shop in six years

However, the Korean CMO which was only conceived in 2011 has not been shy of ambition.

As well as constructing three facilities, the firm has won contracts with Big Pharma firms including Bristol-Myers Squibb and Roche , and last year launched on the Korea Composite Stock Price Index (KOSPI) through a $2bn initial public offering (IPO).

And speaking last week at the first Biopharma Expo, held in Tokyo alongside Interphex Japan, CEO TH Kim said in the six months since going public the CMOs value had doubled from $8bn to $16bn.

Furthermore, he told delegates the firm has branched out into offering development services to its clients. Since earlier this year, the CMO now offers cell line development services, process development services, preclinical and clinical materials, QC services, formulation ad fill/finish.

By becoming a one-stop CDMO service provider, Samsung Biologics can support its vision of reducing its costs, reducing its prices and increasing its value, Kim said.

See original here:

Sun shines on CMO Samsung Biologics to make its psoriasis mAb candidate - BioPharma-Reporter.com

What is psoriasis, what are guttate and pustular psoriasis, is there a cure, what causes it and which celebrities … – The Sun

The skin condition psoriasis affects thousands of men and women across the UK

THE skin condition psoriasis affects thousands of men and women across the UK, with many sufferers believing there is an enormous amount of stigma around the disorder.

Kim Kardashian has revealed she has finally learned to live with the condition which she described as her biggest flaw while model Cara Delevigne is also a sufferer.

Caters News Agency

The condition causes red and crusty patches with silvery scales to flare-up on the skin.

They normally appear on the elbows, knees, scalp, and lower back, but can crop up anywhere on the body.

The patches can sometimes be itchy or sore.

Roughly two per cent of the population are affected by psoriasis and and the number is roughly split equally between men and women.

Its severity varies from person to person and for some people it is merely a small irritation.

In more serious cases it can have a crushing impact on a sufferers life.

E!

Psoriasis isnt fully understood by health professionals but it is thought to be caused by a problem with the immune system.

People with the condition have increased production of skin cells.

Normally skin cells are replaced over a three to four week period.

When someone has psoriasis this process only lasts six or seven days and thats what causes the red patches to emerge.

In people with psoriasis the immune system accidentally attacks healthy skin cells by mistake.

The disorder is thought to run in the family but the precise role genetic plays is unclear.

Many peoples symptoms are triggered meaning the rash will occur when they injure the skin, get a throat infection, or use certain medicines.

Guttate and pustular are two different types of the skin condition psoriasis.

Pustular psoriasis is a rare type of the disease, which causes pustules and pus-filled blisters to form on the skin.

It also makes the skin around the blisters turn red although the pus is not infected and the person is not contagious.

Outbreaks can flare up any time and cases of the condition can include certain medicines, infections and even pregnancy.

Treatment includes using topical creams, light therapy and a combination of therapies.

Meanwhile guttate psoriasis causes pink rashes to form across the chest, arms, legs and scalp.

It is usually caused by an infection and while outbreaks can be a one-off they can also go away and come back.

Infections that cause the condition include tonsillitis and pharyngitis as well as viral infections such as chikenpox and rubella.

The rashes usually go away by themselves, but if not steroid creams and anitibiotics can be prescribed.

A GP can usually spot it simply by its appearance on the skin, but sometimes they will take a small sample to be examined under a microscope.

This will rule out other skin disorders.

Psoriasis has no cure but treatments can reduce the itchiness and the appearance of skin patches.

Topical treatments, meaning creams and ointments, can be rubbed into the skin.

If these arent effective that phototherapy can be used to treat it.

SWNS:South West News Service

This involves the skin being exposed to ultraviolet light.

In truly severe cases oral or injected medicines are available that work throughout the whole body.

One of the more high-profile psoriasis sufferers is Kim Kardashian, who in the past has been seen with big red patches on her arms.

The mum of two,inherited the condition from her mum Kris Jenner and was first diagnosed back in 2010.

Kim told her website: Everyone with psoriasis has different symptoms; sometimes the rashes are itchy, sometimes theyre flaky. Mine flares up from time to time for different reasons.

Model Cara Develvingne also suffers from the skin condition, which is brought on by stress.

Her punishing schedule led her to develop psoriasis which had to be laboriously covered up in thick make-up.

People would put on gloves and not want to touch me because they thought it was, like, leprosy or something, said the 24-year-old.

See the rest here:

What is psoriasis, what are guttate and pustular psoriasis, is there a cure, what causes it and which celebrities ... - The Sun

Psoriasis Treatment: Does Your Diet Matter? – The Good Men Project (blog)

Editors note: This information is provided for educational purposes. It is not meant to diagnose or treat any condition. If you have skin lesions or any health issue, consult a licensed healthcare practitioner in person.

Psoriasis is complex to treat.

In fact, Physician Paul Bechet once said its the antidote to a dermatologists ego (1).

Its an autoimmune disease that causes chronic pain and itching that can severely impact on quality of life.

Many foods and supplements are rumored to help with psoriasis treatment. But does research support these claims?

This article examines the evidence surrounding the relationship between diet and psoriasis.

Psoriasisis a chronic autoimmune disease that causes patches of skin to become inflamed and scaly.

It affects up to 4% of the worlds population (2).

Symptoms occur in flares, and include itching, pain, and skin lesions. Psoriasis may also cause pitted fingernails and toenails, as well as mouth sores.

There are sixtypesof psoriasis. Each type causes a distinctive rash:

Plaque psoriasis.Image source.

Guttate psoriasis.Image source.

Inverse psoriasis.Image source.

Pustular psoriasis.Image source.

Erythrodermic psoriasis.Image source.

Summary:Psoriasis is a chronic condition that causes distinctive skin rashes, itching, inflammation, and pain. Symptoms occur in flares.

Psoriasis is caused by a combination of genetic, environmental, and immunological factors (3).

One large study found that a persons risk increases up to 65% if their parents have psoriasis, and up to 83% if both their parents and siblings have it (4).

Not everyone who carries the gene will develop psoriasis. However, exposure to certain environmental stimuli may increase a persons likelihood of developing the disease.

These stimuli include:

In the presence of both environmental and genetic factors, the immune system malfunctions.

T cells, which normally respond to infection and injury, are mistakenly activated as a result. These cells recruit other immune cells and trigger the release of inflammatorycytokines(13).

This causes the skin cells to die off and regenerate more quickly than they should.

Onset of psoriasis.Image source. Click to enlarge.

The same environmental factors that cause psoriasis can also lead to flares, so its best to limit exposure to them when possible.

Summary:Psoriasis occurs when the immune system mistakenly attacks healthy skin cells. Many people carry a gene for the disease and develop it after exposure to certain environmental factors.

The standardtreatmentsfor psoriasis involve topical and oral medications, as well as ultraviolet light therapy.

There is no scientific proof that diet is an effective treatment for psoriasis on its own.

However, patient testimonials and studies have shown certain diet strategies may help relieve psoriasis symptoms, especially when combined with traditional therapies.

The following sections will focus on foods and nutrients that affect psoriasis severity.

Overweight (in a clinical setting) is characterized by a body mass index (BMI) greater than 24.9.

A BMI greater than 29.9 is classified as obese.

Many studies have found a possible link between obesity and psoriasis.

In one long-term study of more than 67,000 females (14):

Even weight gain of just 10 pounds (4.5 kg) appears to increase risk by up to 8%, regardless of BMI classification (15).

In addition to risk, obesity is also linked to disease severity. This is likely because excessive fat tissue increases production of inflammatory cytokines, which contribute to inflammation and lesions in psoriasis (16,17).

It makes sense then that studies have shown that calorie restriction paired with medication is more effective in reducing psoriasis symptoms than medication alone (18).

Notably, most studies on obesity and psoriasis are observational. This means that researchers arent exactly sure if obesity causes the disease or vice versa.

In any case, psoriasis is linked with several other heart disease risk factors, including high cholesterol, diabetes, and high blood pressure.

Weight loss can reduce heart disease risk for people who are overweight or obese, so it makes sense to maintain a healthy weight (17).

You can calculate your BMIhere.

Summary:Those who are very overweight are more likely to have psoriasis, although researchers arent sure if obesity causes it directly. Maintaining a healthy bodyweight also lowers risk of heart disease which is more common in psoriasis patients.

The autoimmune protocol(AIP) is a diet that eliminates gluten, soy, dairy, legumes, grains, added sugars, nightshades, and alcohol for at least 30 days.

The goal is to identify foods that trigger undesirable autoimmune reactions.

Theres a strong link between psoriasis and other autoimmune diseases. In one large study, those with psoriasis had higher rates of 14 different autoimmune disease than the general population (19).

Patient testimonials suggest that the AIP is helpful for many conditions, including psoriasis.

There have been no clinical trials on the AIP, so theres no scientific evidence to support it. But certain foods eliminated in the AIPincluding gluten and alcoholhave been reported to worsen psoriasis symptoms.

Some small studies have shown a gluten-free diet to improve psoriasis symptoms, but only in those with antibodies againstgliadin(a protein found in gluten). These antibodies would be seen in those with celiac disease or non-celiac gluten sensitivity (20).

Although other studies found no benefits at all, so its all quite unclear at this stage (19).

A stronger link has been suggested between alcohol intake and psoriasis severity.

One review of 28 studies found that alcohol is likely a risk factor for developing psoriasis, and that those with the disease drink more than healthy adults (11).

Its best to avoid alcohol if you have psoriasis, or a strong family history of it.

Summary:Patient testimonials suggest that the autoimmune protocol may help with psoriasis, but this hasnt been formally studied. You should definitely avoid alcohol and potentially gluten too if you are sensitive.

A Western diet high in fat, sodium, and added sugars has been linked to inflammation and autoimmune disease (21).

For this reason a so-called anti-inflammatory diet may ease psoriasis symptoms.

Theres no universal definition for anti-inflammatory diet, but it generally refers to a style of eating that (22,23,24):

An anti-inflammatory diet hasnt been studied in psoriasis specifically, but systemic inflammation is a key feature of the disease.

This diet pattern has also been shown to help with certain autoimmune diseases, so in theory and based on patient testimonials it may be beneficial (18,25,26).

Patient testimonials also indicate that an anti-inflammatory eating pattern is helpful for arthritis. As such, it may be useful for relieving pain and stiffness in thosewith psoriatic arthritis(27,28).

The diet is similar in many ways to the Mediterranean diet, which includes fish and lean meats, vegetables, fruits, healthy fats, whole grains, and legumes.

In one study, stronger adherence to the Mediterranean diet was associated with fewer psoriasis symptoms. Further, those with fewer symptoms ate more fruit, vegetables, legumes, nuts, and fish and less meat (29).

More human studies are needed to know if the Mediterranean diet is beneficial for psoriasis. But given itsother health benefits, such as reducing heart disease risk, it makes sense to eat this way regardless of its effects on skin (30).

Summary:Anti-inflammatory and Mediterranean diets emphasize healthy fats, fruits, vegetables, and whole grains. One study linked the Mediterranean diet with improved psoriasis symptoms.

Several dietary supplements have been reported tohelp with psoriasis treatment.

Fish oil capsules contain the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA).

Its known for its anti-inflammatory properties.

In one literature review, 12 of 15 studies found fish oil to improve psoriasis severity (31).

The strongest evidence is in support of high-dose intravenous (IV) omega-3 infusions for plaque and guttate psoriasis. However, this isnt a typical therapy, and wouldnt be readily available to most patients (32,33).

One small observational study found that oral fish oil supplements significantly reduced psoriasis severity and improved quality of life when paired with prescription ointment. Volunteers in this study received 640 mg of DHA plus EPA per day for eight weeks (34).

Change in Psoriasis Area and Severity Index (PASI) overdurationof study for fish oil plus ointment group compared to ointment only group.Lowerscore is better. Click to enlarge.

Larger clinical trials are needed to confirm these effects but it looks promising.

Probioticsare beneficial bacteria that we eat.

They have been the focus of many studies recently because of the interaction between the gutmicrobiomeand various health conditions, including psoriasis.

One study found adults with psoriasisespecially psoriatic arthritisto have less diversity in gut bacteria than healthy adults. The researchers likened the bacterial profile in psoriasis to that of inflammatory bowel disease, which often responds well to probiotics (35,36).

In another study, 23 patients with mild to moderate plaque psoriasis received the probioticBifidobacterium infantis35264 at a dose of 11010colony forming units (CFU) per day for eight weeks.

Researchers found that most blood markers of inflammation (CRP and TNF-) were significantly lower at eight weeks (37).

Other probiotic strains havent been studied specifically in psoriasis yet.

Vitamin D helps regulate the immune system by inhibiting T cell multiplication and limiting cytokine production (38).

Because T cells and cytokines play key roles in psoriasis, and because vitamin D deficiency is common among those with autoimmune disease, its been studied as a possible psoriasis treatment (38).

One literature review found vitamin D supplements and ointments to be as effective as corticosteroids in easing symptoms. The benefits were even greater when vitamin D was used with a high-dose steroid ointment (39).

In one study, 85 psoriasis patients began taking 0.5 micrograms (g) of oral calcitriol (the active form of vitamin D3) per day. Researchers increased the daily dosage by 0.5 g every two weeks, as long as lab tests were normal. Volunteers received treatment for between 6-36 months.

Patients saw significant reductions in Psoriasis Area and Severity Index (PASI) scores at six months and even greater improvements at 24 months. Nearly 27% had complete improvement in symptoms, while 88% had some improvement (31,40).

The results are promising, and no negative side effects were reported.

But high quality clinical trials are needed to make firm conclusions.

Antioxidants are molecules that protect cells againstoxidative stress.

A handful of studies have linked oxidative stress and psoriasis, and certain antioxidants have been proposed as a supplemental therapy for the disease (41,42).

Seleniumis an antioxidant mineral found in vegetables, meat, fish, poultry, grains, and eggs.

Evidence is conflicting as to whether selenium deficiency directly contributes to psoriasis risk (43,44).

Small studies, however, have found that it may play an indirect role. Selenium helps inhibit activity of a protein calledosteopontin, and high osteopontin levels are thought to increase psoriasis risk (45,46).

Its unclear whether selenium supplements are helpful in reducing symptoms though.

Continue reading here:

Psoriasis Treatment: Does Your Diet Matter? - The Good Men Project (blog)

Nail findings distinguish between psoriasis, psoriatic arthritis – Healio

Nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis, with transverse grooves being a significant factor, according to recently published study results in the Journal of the American Academy of Dermatology.

Researchers conducted a retrospective analysis between July 2003 and February 2015 at the dermatology department of St. Lukes International Hospital in Tokyo of 118 patients with psoriatic arthritis (PsA; mean age at first visit, 47.7 years; 46.6% female) and 974 patients with psoriasis and without arthritis (mean age at first visit, 50.9 years; 36.2% female).

They used the Psoriasis Area and Severity Index to measure skin lesion severity, and evaluated nine nail characteristics.

Patients with PsA had a 67.6% incidence of nail involvement. Onocholysis (P < .01)), transverse grooves (P < .01), nail-plate crumbling (P = .04) and splinter hemorrhages (P < .01) were more frequent in patients with PsA compared with patients with just psoriasis.

Multivariate logistic regression analysis found that female sex (OR = 2.54; 95% CI, 1.53-4.22), presence of transverse grooves (OR = 5.01; 95% CI, 2.31=-10.8), onocholysis (OR = 2.37; 95% CI, 1.36-4.15) and splinter hemorrhages (OR = 3.51; 95% CI, 1.17-10.6) were associated with arthritis.

Transverse grooves were significantly associated with distal interphalangeal arthritis (P = .05) and enthesitis (P = .03).

Nail findings may be used to discriminate between patients with PsA and [psoriasis without arthritis], the researchers concluded. In particular, transverse grooves are significantly associated with PsA. These findings may be useful for making early diagnoses of PsA and they may contribute to improved treatment. We recommend that physicians note these findings in patients with psoriasis, as they may indicate [distal interphalangeal] arthritis or enthesitis. by Bruce Thiel

Disclosure: The researchers report no relevant financial disclosures.

Read more:

Nail findings distinguish between psoriasis, psoriatic arthritis - Healio

Progress On Psoriasis, From ‘Last In Line’ To Often First, But At A Price – WBUR

wbur Narrating Medicine A new category of drugs, biologics, inhibits elements of the immune system that fuel inflammation. Humira is an example of a biologic. (David J. Phillip/AP)

My body is a walking encyclopedia covering 40 years of psoriasis treatments.

I've had hundreds of cortisone injections shot into my scalp, arms and legs. Thick black tar applied to my head so it could be absorbed into the scaly red plaques that surfaced when my condition flared. Salicylic acid shampoos that stunk like hot asphalt. Light box treatments. Methotrexate and cyclosporine, immune system suppressants prescribed variously for cancers, rheumatoid arthritis and organ transplant recipients.

And still, it was there. Always, or nearly always. The inflamed, flaking, cracking skin. Wavy ridges in my fingernails. Hundreds of hours spent in dermatology offices. Thousands of attempts to hide painful, embarrassing skin patches that would appear on elbows, knees, scalp and other surprising places when I was under stress, on a deadline, or for no obvious reason at all.

I am not alone. Last year, the World Health Organizations Global Report on Psoriasis called the disease a "serious global problem with at least 100 million individuals affected worldwide." That includes more than 7 million Americans. We are legion. With lesions.

Psoriasis is a mystery, a disease of the immune system with no clear cause or cure. For years, traditional medications that were developed initially for arthritis, Crohn's disease or other immune conditions eventually dropped down the pharmaceutical food chain to psoriasis patients.

Lately, though, that landscape has been shifting, with the advent of a new category of drugs: biologics, genetically engineered proteins derived from human genes. Usually injections that a patient administers at home, they inhibit elements of the immune system that fuel inflammation.

Humira, Enbrel and Cosentyx are examples of biologics. And a recent paper in The Lancet shows promise for a new biologic called tildrakizumab. Designed primarily for psoriasis, it may ultimately have additional applications.

Tildrakizumab differs from earlier, similar biologics by targeting a very specific immune system pathway.

"The breakthrough is that we have continued to refine our treatments to those that are likely to be most effective against psoriasis but less likely to affect other important pathways at the same time," says study senior author Dr. Alexa Kimball, a dermatologist and presidentof Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center in Boston.

From Accidental Findings To'First In Line'

Psoriasis treatments have mostly been accidental discoveries, Kimball said.

Occasionally, a psoriasis patient who needed an organ transplant would end up being treated with cyclosporine, and it was amazing how a drug like that cleared the skin, sheexplained. And so there was this sort of accidental-incidental way that early psoriasis treatments were discovered.

Treatment evolved with those incidental discoveries, including traditional medications such as cortisone and cyclosporine, which are still prescribed frequently for mild to moderate psoriasis.

The first generation of biologics to treat psoriasis entered the market in the early 2000s. They have fewer side effects than traditional medications (the cyclosporine Im currently taking can impact liver and kidney function), are generally well tolerated, and the majority of patients don't mind injecting themselves.

But they still carry the risks of immune suppression, including reactivation of tuberculosis, and increased susceptibility to viral infections and certain cancers.

Immune proteins evolved to protect us from infection, explained immunologist Dr. Sarah Gaffen of the University of Pittsburgh. So when you start blocking them, youre going to raise the specter of some sort of infectious disease.

The good news is that highly focused drugs, like tildrakizumab, do mean greater improvement on psoriasis symptoms with far fewer side effects. Gaffen refers to the targeted nature of biologics as exquisitely specific.

And because psoriasis isnt a life or death matter, patients who are enrolled in research protocols can also be put on placebos with limited risk to their overall health. Thats not an option with arthritis or Crohns disease, where irreversible harm might be done without ongoing treatment. And, as Kimball added, The results are right in front of your face with psoriasis. You can see such a dramatic improvement.

More good news: In drug development these days, psoriasis has been gaining traction as a proof of principle disease, according to Kimball. If a medication did well on psoriasis, it was pretty likely to do well in other [immune] areas.

"The paradigm has completely switched," she added. "Psoriasis was last in line 10 or 15 years ago. Now its often first.

High Hopes, High Prices

Now for the not-so-good news, long familiar to anyone who takes biologics: the price tags.

While tildrakizumab isnt yet on the market, other biologics are, and I was recently introduced to the challenge of acquiring them.

I was having a severe psoriasis flare. Red, cracked, inflamed skin, so painful it was difficult to bend my arms or sit. My dermatologist prescribed Humira.

The prescription was filled before my insurance company had a chance to determine coverage. I asked the pharmacist how much the medication would cost if I paid out of pocket.

She looked at the computer screen, and then at me. Then again at the computer. I raised my eyebrows.

Do you want to guess? she asked me.

$600, I ventured.

She shook her head.

$6,000?

She shook her head again. I shrugged. She paused. $30,000.

$30,000? I repeated. I might as well buy a car.

You should, she said. Because thats not even for the whole year.

Kimball confirmed the cost. Usually we expect these drugs at list prices to run around $50,000 a year. They are very expensive drugs, she said.

Needless to say, I postponed the Humira. I may start on it this fall, when it's fully covered.

In 2016, Humira grossed over $16 billion, putting it in first place for the best-selling drug of the year, according to Genetic Engineering & Biotechnology News, a trade publication.

According to the WHO report, treatments for psoriasis around the world --whether simple creams or complex biologics --are either unavailable or are not reimbursed for the majority of patients. And its hard to imagine anyone paying $50,000 to Walgreens out of a checking account.

Yet biologics offer the greatest advances yet in treating immune-regulated diseases. And tildrakizumab, while developed for moderate to severe psoriasis, may be one that also holds the potential to benefit other diseases in the future.

I hope those of us who need it will have access. Kimball recognizes this hurdle: "Figuring out how to get this right," she said, "so we ensure access to the patients who need these medications, is one of the things that absolutely keeps me up at night."

Beth Jones is a Boston-based writer and educator.

The rest is here:

Progress On Psoriasis, From 'Last In Line' To Often First, But At A Price - WBUR